-
1
-
-
27744514865
-
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial
-
Goekoop-Ruiterman YPMY, de Vries-Bouwstra JKJ, Allaart CFC, van Zeben DD, Kerstens PJSMP, Hazes JMWJ, Zwinderman AHA, Ronday HKH, Han KHK, Westedt MLM, Gerards AHA, van Groenendael JHLMJ, Lems WFW, van Krugten MVM, Breedveld FCF, Dijkmans BACB: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005, 52:3381-3390.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3381-3390
-
-
Goekoop-Ruiterman, Y.P.M.Y.1
de Vries-Bouwstra, J.K.J.2
Allaart, C.F.C.3
van Zeben, D.D.4
Kerstens, P.J.S.M.P.5
Hazes, J.M.W.J.6
Zwinderman, A.H.A.7
Ronday, H.K.H.8
Han, K.H.K.9
Westedt, M.L.M.10
Gerards, A.H.A.11
van Groenendael, J.H.L.M.J.12
Lems, W.F.W.13
van Krugten, M.V.M.14
Breedveld, F.C.F.15
Dijkmans, B.A.C.B.16
-
2
-
-
21044435315
-
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis
-
Manzo A, Paoletti S, Carulli M, Blades MC, Barone F, Yanni G, FitzGerald O, Bresnihan B, Caporali R, Montecucco C, Uguccioni M, Pitzalis C: Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 2005, 35:1347-1359.
-
(2005)
Eur J Immunol
, vol.35
, pp. 1347-1359
-
-
Manzo, A.1
Paoletti, S.2
Carulli, M.3
Blades, M.C.4
Barone, F.5
Yanni, G.6
FitzGerald, O.7
Bresnihan, B.8
Caporali, R.9
Montecucco, C.10
Uguccioni, M.11
Pitzalis, C.12
-
3
-
-
59249104722
-
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium
-
Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C: Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009, 6:e1.
-
(2009)
PLoS Med
, vol.6
-
-
Humby, F.1
Bombardieri, M.2
Manzo, A.3
Kelly, S.4
Blades, M.C.5
Kirkham, B.6
Spencer, J.7
Pitzalis, C.8
-
4
-
-
0033869054
-
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
-
Kroot EJE, de Jong BAB, van Leeuwen MAM, Swinkels HH, van den Hoogen FHF, Hof MMV, van de Putte LBL, van Rijswijk MHM, van Venrooij WJW, van Riel PLP: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000, 43:1831-1835.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1831-1835
-
-
Kroot, E.J.E.1
de Jong, B.A.B.2
van Leeuwen, M.A.M.3
Swinkels, H.H.4
van den Hoogen, F.H.F.5
Hof, M.M.V.6
van de Putte, L.B.L.7
van Rijswijk, M.H.M.8
van Venrooij, W.J.W.9
van Riel, P.L.P.10
-
5
-
-
84904975988
-
Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study
-
Kubo S, Saito K, Hirata S, Fukuyo S, Yamaoka K, Sawamukai N, Nawata M, Iwata S, Mizuno Y, Tanaka Y: Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study. Mod Rheumatol 2013, 24:42-51.
-
(2013)
Mod Rheumatol
, vol.24
, pp. 42-51
-
-
Kubo, S.1
Saito, K.2
Hirata, S.3
Fukuyo, S.4
Yamaoka, K.5
Sawamukai, N.6
Nawata, M.7
Iwata, S.8
Mizuno, Y.9
Tanaka, Y.10
-
6
-
-
0035169196
-
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients
-
Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, Yoshikawa H, Ochi T: Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 2001, 166:650-655.
-
(2001)
J Immunol
, vol.166
, pp. 650-655
-
-
Shi, K.1
Hayashida, K.2
Kaneko, M.3
Hashimoto, J.4
Tomita, T.5
Lipsky, P.E.6
Yoshikawa, H.7
Ochi, T.8
-
7
-
-
55849110806
-
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint
-
Manzo A, Vitolo B, Humby F, Caporali R, Jarrossay D, Dell'Accio F, Ciardelli L, Uguccioni M, Montecucco C, Pitzalis C: Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 2008, 58:3377-3387.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 3377-3387
-
-
Manzo, A.1
Vitolo, B.2
Humby, F.3
Caporali, R.4
Jarrossay, D.5
Dell'Accio, F.6
Ciardelli, L.7
Uguccioni, M.8
Montecucco, C.9
Pitzalis, C.10
-
8
-
-
84889052781
-
A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium
-
Kobayashi S, Murata K, Shibuya H, Morita M, Ishikawa M, Furu M, Ito H, Ito J, Matsuda S, Watanabe T, Yoshitomi H: A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. Arthritis Rheum 2013, 65:3063-3072.
-
(2013)
Arthritis Rheum
, vol.65
, pp. 3063-3072
-
-
Kobayashi, S.1
Murata, K.2
Shibuya, H.3
Morita, M.4
Ishikawa, M.5
Furu, M.6
Ito, H.7
Ito, J.8
Matsuda, S.9
Watanabe, T.10
Yoshitomi, H.11
-
9
-
-
70349249529
-
Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts
-
Chan TD, Gatto D, Wood K, Camidge T, Basten A, Brink R: Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J Immunol 2009, 183:3139-3149.
-
(2009)
J Immunol
, vol.183
, pp. 3139-3149
-
-
Chan, T.D.1
Gatto, D.2
Wood, K.3
Camidge, T.4
Basten, A.5
Brink, R.6
-
10
-
-
35348861537
-
CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis
-
Wengner AM, Höpken UE, Petrow PK, Hartmann S, Schurigt U, Bräuer R, Lipp M: CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum 2007, 56:3271-3283.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 3271-3283
-
-
Wengner, A.M.1
Höpken, U.E.2
Petrow, P.K.3
Hartmann, S.4
Schurigt, U.5
Bräuer, R.6
Lipp, M.7
-
11
-
-
79952011168
-
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis
-
Rosengren S, Wei N, Kalunian KC, Kavanaugh A, Boyle DL: CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis. Rheumatology 2011, 50:603-610.
-
(2011)
Rheumatology
, vol.50
, pp. 603-610
-
-
Rosengren, S.1
Wei, N.2
Kalunian, K.C.3
Kavanaugh, A.4
Boyle, D.L.5
-
12
-
-
84901634893
-
Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels
-
Jones JD, Hamilton BJ, Challener GJ, de Brum-Fernandes AJ, Cossette P, Liang P, Masetto A, Ménard HA, Carrier N, Boyle DL, Rosengren S, Boire G, Rigby WF: Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels. Arthritis Res Ther 2014, 16:R103.
-
(2014)
Arthritis Res Ther
, vol.16
, pp. R103
-
-
Jones, J.D.1
Hamilton, B.J.2
Challener, G.J.3
de Brum-Fernandes, A.J.4
Cossette, P.5
Liang, P.6
Masetto, A.7
Ménard, H.A.8
Carrier, N.9
Boyle, D.L.10
Rosengren, S.11
Boire, G.12
Rigby, W.F.13
-
13
-
-
84895428992
-
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
-
Horslev-Petersen K, Hetland ML, Junker P, Podenphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Horn HC, Ammitzboll CG, Jorgensen A, Krintel SB, Raun J, Johansen JS, Ostergaard M, Stengaard-Pedersen K, OPERA study-group, Slot O, Nielsen LK, Skjodt H, Majgaard O, Lorenzen T, Kowalski M, Johansen IL, Pedersen PM, Manilo N, Bliddal H: Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis 2013, 73:654-661.
-
(2013)
Ann Rheum Dis
, vol.73
, pp. 654-661
-
-
Horslev-Petersen, K.1
Hetland, M.L.2
Junker, P.3
Podenphant, J.4
Ellingsen, T.5
Ahlquist, P.6
Lindegaard, H.7
Linauskas, A.8
Schlemmer, A.9
Dam, M.Y.10
Hansen, I.11
Horn, H.C.12
Ammitzboll, C.G.13
Jorgensen, A.14
Krintel, S.B.15
Raun, J.16
Johansen, J.S.17
Ostergaard, M.18
Stengaard-Pedersen, K.19
Slot, O.20
Nielsen, L.K.21
Skjodt, H.22
Majgaard, O.23
Lorenzen, T.24
Kowalski, M.25
Johansen, I.L.26
Pedersen, P.M.27
Manilo, N.28
Bliddal, H.29
more..
-
14
-
-
84881243972
-
A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients
-
Kragstrup TW, Vorup-Jensen T, Deleuran B, Hvid M: A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. SpringerPlus 2013, 2:263.
-
(2013)
SpringerPlus
, vol.2
, pp. 263
-
-
Kragstrup, T.W.1
Vorup-Jensen, T.2
Deleuran, B.3
Hvid, M.4
-
15
-
-
84856979170
-
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs
-
Bugatti S, Manzo A, Benaglio F, Klersy C, Vitolo B, Todoerti M, Sakellariou G, Montecucco C, Caporali R: Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs. Arthritis Res Ther 2012, 14:R34.
-
(2012)
Arthritis Res Ther
, vol.14
, pp. R34
-
-
Bugatti, S.1
Manzo, A.2
Benaglio, F.3
Klersy, C.4
Vitolo, B.5
Todoerti, M.6
Sakellariou, G.7
Montecucco, C.8
Caporali, R.9
-
16
-
-
79955564865
-
Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint
-
Meeuwisse CM, van der Linden MP, Rullmann TA, Allaart CF, Nelissen R, Huizinga TW, Garritsen A, Toes RE, van Schaik R, van der Helm-van Mil AH: Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint. Arthritis Rheum 2011, 63:1265-1273.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1265-1273
-
-
Meeuwisse, C.M.1
van der Linden, M.P.2
Rullmann, T.A.3
Allaart, C.F.4
Nelissen, R.5
Huizinga, T.W.6
Garritsen, A.7
Toes, R.E.8
van Schaik, R.9
van der Helm-van Mil, A.H.10
-
17
-
-
49449100341
-
Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor a, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor
-
Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC: Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor a, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum 2008, 58:2257-2267.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2257-2267
-
-
Rioja, I.1
Hughes, F.J.2
Sharp, C.H.3
Warnock, L.C.4
Montgomery, D.S.5
Akil, M.6
Wilson, A.G.7
Binks, M.H.8
Dickson, M.C.9
-
18
-
-
0029548868
-
Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses
-
Le Hir M, Bluethmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, Ryffel B, Eugster HP: Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses. J Inflamm 1995, 47:76-80.
-
(1995)
J Inflamm
, vol.47
, pp. 76-80
-
-
Le Hir, M.1
Bluethmann, H.2
Kosco-Vilbois, M.H.3
Muller, M.4
di Padova, F.5
Moore, M.6
Ryffel, B.7
Eugster, H.P.8
-
19
-
-
0035881240
-
Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle
-
Mandik-Nayak L, Huang G, Sheehan KC, Erikson J, Chaplin DD: Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle. J Immunol 2001, 167:1920-1928.
-
(2001)
J Immunol
, vol.167
, pp. 1920-1928
-
-
Mandik-Nayak, L.1
Huang, G.2
Sheehan, K.C.3
Erikson, J.4
Chaplin, D.D.5
-
20
-
-
0035164357
-
Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells
-
Wang Y, Wang J, Sun Y, Wu Q, Fu YX: Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J Immunol 2001, 166:330-337.
-
(2001)
J Immunol
, vol.166
, pp. 330-337
-
-
Wang, Y.1
Wang, J.2
Sun, Y.3
Wu, Q.4
Fu, Y.X.5
|